CytoDyn Announces Investment Community Conference Call for March 24, 2016

VANCOUVER, Wash., March 22, 2016 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating human immunodeficiency virus (HIV) infection, today announced that management will hold an investment community conference call on Thursday, March 24, 2016, at 1:00 p.m. PT / 4:00 p.m. ET to provide an update on clinical and regulatory developments.

Conference Call and Webcast Instructions
CytoDyn’s management team will host a conference call and live audio webcast on March 24, 2016 at 1:00 p.m. PT / 4:00 p.m. ET.

Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

A live audio webcast may also be accessed via the Investors section of CytoDyn’s corporate web site at, and will be archived for 60 days. Web participants are encouraged to go to the web site 15 minutes prior to the start of the call to register, download and install any necessary software.

A replay of the conference call will be available until May 24, 2016. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international); Conference ID: 13578723.

CONTACTS: Investors: LHA Jody Cain Office: 310-691-7100 E-mail: Media: Nader Pourhassan, Ph.D. Office: 360-980-8524 E-mail:

Source:CytoDyn Inc.